These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

713 related items for PubMed ID: 22728934

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. FGF23 Actions in CKD-MBD and other Organs During CKD.
    Sun T, Yu X.
    Curr Med Chem; 2023; 30(7):841-856. PubMed ID: 35761503
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Klotho/FGF23 Axis in CKD.
    Tsuchiya K, Nagano N, Nitta K.
    Contrib Nephrol; 2015; 185():56-65. PubMed ID: 26023015
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients.
    Fayed A, El Nokeety MM, Heikal AA, Abdulazim DO, Naguib MM, Sharaf El Din UAA, Vascular Calcification Group (VCG).
    Ren Fail; 2018 Nov; 40(1):226-230. PubMed ID: 29619868
    [Abstract] [Full Text] [Related]

  • 50. Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications.
    Kaur R, Singh R.
    Life Sci; 2022 Dec 15; 311(Pt B):121148. PubMed ID: 36336124
    [Abstract] [Full Text] [Related]

  • 51. Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?
    Oliveira RB, Cancela AL, Graciolli FG, Dos Reis LM, Draibe SA, Cuppari L, Carvalho AB, Jorgetti V, Canziani ME, Moysés RM.
    Clin J Am Soc Nephrol; 2010 Feb 15; 5(2):286-91. PubMed ID: 19965540
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. The intervention effect of zuogui pill on chronic kidney disease-mineral and bone disorder regulatory factor.
    Ma X, He L.
    Biomed Pharmacother; 2018 Oct 15; 106():54-60. PubMed ID: 29957466
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
    Sánchez Fructuoso AI, Maestro ML, Pérez-Flores I, Valero R, Rafael S, Veganzones S, Calvo N, De la Orden V, De la Flor JC, Valga F, Vidaurreta M, Fernández-Pérez C, Barrientos A.
    Nephrol Dial Transplant; 2012 Nov 15; 27(11):4227-35. PubMed ID: 23144073
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.